Source: Eur Respir Rev 2010; 19: 109-112
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Cerveri I., Brusasco V.. Revisited role for mucus hypersecretion in the pathogenesis of COPD. Eur Respir Rev 2010; 19: 109-112

Member's Comments

No comment yet.

Related content which might interest you: Chronic mucus hypersecretion in severe asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies Source: Eur Respir J 2008; 31: 70-77 Year: 2008 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002 Bronchial hyperreactivity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 424s Year: 2003 Small airway inflammation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001 Features of the bronchial mucosa in heavy smokers with and without chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Disease of the airways in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 41S-49S Year: 2001 Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Asthma versus chronic obstructive pulmonary disease Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=195 Year: 2003 Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD Source: Eur Respir J 2015; 45: 60-75 Year: 2015 The role of small airways in obstructive airway diseases Source: Eur Respir Rev 2011; 20: 23-33 Year: 2011 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Airway pathology in asthma Source: Eur Respir J 2001; 18: 18S-23S Year: 2001 "Nitosative stress" in the bronchial mucosa of severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 363s Year: 2005